Objective: The purpose was to monitor implanted seeds and to determine factors contributing to seed migration after permanent prostate brachytherapy. Methods: Sixty-two consecutive patients with Stage 1 prostate cancer who underwent brachytherapy with 125 I seeds between February 2008 and May 2009 were studied prospectively. On post-operative days 1, 7 and 30, scintigraphy was added to conventional radiography to monitor the migration of the implanted seeds. The prostate volume was measured during the pre-planning stage using ultrasound and during the post-planning stage using computed tomography on post-operative days 0 and 30. Magnetic resonance imaging was performed on day 30. Results: Of the 4843 seeds implanted in the prostates of 62 patients, 108 seeds (2.2%) in 43 patients (69.4%) exhibited seed migration. Thirty-five seeds could not be identified using any of the imaging modalities and were likely passed during urination (0.7% of the total number of seeds). The maximum number of migrated seeds in one patient was 10 of the 85 implanted seeds. The fraction of patients with seed migration or loss increased from 27.4% on day 1 to 69.4% on day 30. The number of seeds that had migrated from the prostate increased from 48 (0.1% of the total number of seeds) on 1 day to 78 (1.0%) on day 7 and 108 (2.2%) on day 30. Of the seeds lost from the prostate, 38.9% embolized to the lungs. The seed loss during the first post-operative month was closely correlated with the swelling of the prostate gland between the pre-planning measurement and the post-planning measurement performed on day 0 (P , 0.0001). Conclusions: Prostate swelling between the pre-planning and post-planning (day 0) measurements was significantly associated with seed migration, and adequate attention should be given to this issue.
INTRODUCTION
Transperineal, ultrasound (US)-guided interstitial brachytherapy for the treatment of prostate cancer utilizes permanently implanted seeds containing radioactive sources of I-125 to treat early stage prostate cancer. Although these seeds allow dose escalation in regions of suspected tumor formation and dose reduction near critical normal structures, poor seed fixity may increase the possibility of individual seeds migrating away from the prostate. During seed insertion, the needle may puncture the urethral mucosa; such punctures allow nearby free seeds to pass via the urethra. Similarly, needles that perforate or transect veins within the periprostatic venous plexus may allow protruding free seeds to enter the systemic venous circulation, traveling in the blood stream until they lodge in small caliber vessels, such as pulmonary capillaries (1) . Seed migration occurs during dose delivery and obviously has ramifications on implant dosimetry and on the iatrogenic irradiation of normal tissues. Seed migration may cause an insufficient dosimetry in the prostate; in extreme cases, seed re-implantation may be needed to compensate for a poor V100 (the fractional volume of the prostate that receives 100% of the prescription dose) or D90 (the dose that covers 90% of the prostate volume outlined on post-implant computed tomography images) (2) . Some reports based on conventional X-ray imaging have revealed several factors that contribute to seed migration, such as the total number of seeds, the number of seeds inserted in the extra prostatic region, and the prostate volume (3 -5) .
We have been using scintigraphy to monitor migrated seeds. This technique enables a much higher sensitivity than conventional radiography (100 vs. 35%, P ¼ 0.016) (6) . The purpose of the present study was to determine the factors contributing to seed migration using scintigraphy in addition to conventional radiography.
PATIENTS AND METHODS

PATIENT SELECTION
A prospective study of patients undergoing prostate brachytherapy at a single center between February 2008 and May 2009 was performed ( Table 1) . The study population consisted of 62 consecutive patients who underwent prostate brachytherapy for clinical T1c-T2b (2003 AJCC) carcinoma of the prostate gland. Three patients underwent combined external beam radiation therapy and 16 underwent pre-implant hormonal therapy to downsize the prostate volume. A total of 4843 seeds were implanted in these 62 patients. On average, 78 seeds were implanted per patient (range, 45-102 seeds).
IMPLANT PLANNING
Pre-planning was routinely performed 3 weeks prior to brachytherapy. A transrectal probe was used to obtain an axial image of the prostate (0.5-cm slice spacing). The pre-implant clinical target volume (CTV) was defined as the entire US image of the prostate. The pre-implant planning target volume includes a 2 -5-mm margin on the pre-implant CTV superiorly, inferiorly and laterally. Model 6711 Amersham Oncoseed 125-Iodine sources with an activity of 15.3 MBq per seed were used for all implantations.
DOSE PRESCRIPTION
The calculation algorithms and seed parameters recommended by the American Association of Physicists in Medicine (AAPM) Task Group #43 (TG-43) were used for pre-planning and post-operative dosimetry. To calculate the prostate volume, ultrasonography was used for pre-planning (3 weeks before the operation) and during the operation.
IMPLANT PROCEDURE
All the implantations were performed whereas the patients were in a dorsal lithotomic position under epidural anesthesia by a brachytherapy team with extensive experience performing permanent prostate seed implantation. The sources were implanted transperineally through predetermined template apertures using real-time transrectal US guidance and on-demand fluoroscopy. The transrectal US equipment was calibrated in the x, y and z directions to ensure accurate seed implantation in the longitudinal and transverse planes. One or two additional sources were often placed in potentially under-dosed regions.
POST-IMPLANTATION DATA COLLECTION
For the post-planning measurements ( performed on postoperative days 0 and 30), the dosimetry was evaluated using computed tomography (CT) (Asteion; Toshiba). The following CT protocol was used for prostate brachytherapy: 120 kV, 300 mA, field of view of 200, slice thickness of 2.0 mm and helical pitch of 3.5. Sagittal and coronal image references were available for delineating the prostate. On post-operative day 30, magnetic resonance imaging (MRI) (Magnetom Siemens) and CT examinations were also performed for post-planning. The MRI protocol was as follows: T2-weighted sequences in axial, coronal and sagittal orientations and an axial T1-weighted sequence at 1.5 T using a combined endorectal-body phased-array coil (7). All 62 In addition to the prostate, the rectum, bladder and urethra were also contoured on each slice.
SOURCE IDENTIFICATION
Follow-up X-rays of the chest ( posterior -anterior and lateral projections), abdomen and pelvis and scintigraphy examinations were performed on post-operative days 1, 7 and 30. For the scintigraphies, we utilized a g-camera (e.cam; Siemens) with a low-energy, high-resolution collimator tuned to an energy level of 35 keV with a 70% window width to cover all three photopeaks (27.4, 31.4 and 35.5 keV) emitted by the 125 I seeds. To localize the migrated seeds, we composed a fusion image of the migrated seed and the patient's contours with the help of fusion software. To obtain the contour image, we had the patients lie on a flood-source phantom filled with a 99m Tc medium for 1 min (6). Seeds were scored as having migrated if they were visualized outside the true anatomic prostate using the above-mentioned modalities. Seeds were scored as missing when the number of seeds implanted during brachytherapy exceeded the number of seeds identified using the four imaging modalities: CT, MR, conventional X-ray and scintigraphy. All the images were routinely peer-reviewed by expert radiologists. As for the missing seeds, we provided each patient with a specially designed lead case and instructed them to collect and bring any urinated seeds back to our institution safely. Note that a whole body scintigraphic scan from head to toe was performed for all the patients to monitor each and every seed. The length of the follow-up period and the time until each set of examinations were determined based on the date of the initial brachytherapy implantation.
The study protocol was in accordance with the ethical standards of the Helsinki Declaration of 1975, revised in 2000, and was approved by the internal review board of the International Medical Center of Japan, Toyama Hospital (from April 2010, the name of this hospital was changed to the National Center for Global Health and Medicine). Informed consent was obtained from all the patients for the use of their medical records in this prospective medical research.
STATISTICAL ANALYSIS
Each patient was categorized as either migration negative or migration positive. We then compared and statistically analyzed the swelling of the prostate gland between the preplanning and initial post-planning (day 0) measurements for each group. A probability value of P , 0.05 using the Student t-test, assuming unequal variances, was considered statistically significant (SPSS Inc., Chicago, IL, USA).
RESULTS
INCIDENCE OF SEED MIGRATION
Our periodic monitoring of the implanted seeds showed serial seed migration (Tables 2 and 3 ). To our knowledge, regular whole body monitoring of patients with implanted seeds has not been previously reported. We observed 73 migrated seeds and 35 lost seeds among all the patients until day 30. Most of the migrated seeds lodged in the lungs and pelvis (Fig. 1) . Forty-two seeds had embolized to the lungs (accounting for 38.9% of the total migrated seeds). We observed two seeds that shifted from the left to right lobe between post-operative days 7 and 30. One seed traveled to the right kidney, and two seeds traveled to the thigh in two patients (Fig. 2) . Although such migrations are thought to be rare, these cases indicate the possibility of migration to such areas. The total number of implanted seeds was 4843. The figures in parentheses represent the percentage of the total number of seeds. The total number of patients was 62. The figures in parentheses represent the percentage of the total number of patients.
Of the 4843 seeds that were implanted, a total of 48 seeds cumulatively migrated out of the prostate on postoperative day 1 (rate of migration: 0.1% of the number of implanted seeds). On post-operative day 7, the number of cumulatively migrated seeds increased to 78 (rate of migration: 1.6%); on post-operative day 30, the number increased to 108 (rate of migration: 2.2%). Thirty-five seeds were missing and may have been passed during urination. The number of newly migrated seeds per day demonstrated that most of the seed loss happened within Day 1: 48 seeds migrated within day 1, 5 seeds migrated between days 2 and 7 and 1.3 seeds migrated between days 8 and 30 (Table 2) . Of the 62 patients, 43 exhibited cumulative seed migration (rate of migration: 69.4%). The percentage of patients experiencing seed loss increased from 27.4% on day 1 to 69.4% on day 30. The number of patients with new migration was 17 within day 1, 1.16 between days 2 and 7, and 0.83 between days 8 and 30 (Table 3 ). The maximum number of migrated seeds in a single patient was 10 out of 85 implanted seeds.
VARIATION IN PROSTATE VOLUME
The prostate volume varied from the pre-planning measurement (performed 3 weeks before the operation) to the first post-planning measurement performed on postoperative day 0 and the second post-planning measurement performed on post-operative day 30 (Table 4 ). The increase in prostate volume observed on post-operative day 0 was thought to have been induced by seed insertion and had resolved after 1 month. In the present study, we focused on the percentage of prostate swelling between the pre-planning and initial post-planning (day 0) measurements. A statistical analysis of the deviation in prostate volume, as well as other parameters, was performed separately for the migration-negative and the migration-positive groups (Table 5 ). Statistically significant differences in the percentage of prostate swelling between the pre-planning and initial post-planning measurements were observed (P , 0.0001).
We did not find significant differences in the other results: the number of implanted seeds (P ¼ 0.424), the number of seeds placed in the periprostatic region (P ¼ 0.957), the number of needles used for implantation (P ¼ 0.865), the number of percutaneous needle insertions (P ¼ 0.631), the prostate volume at the pre-planning stage (ml) (P ¼ 0.228), the prostate volume on post-planning day 0 (ml) Figure 1 . The dots in this figure show the final location of the migrated seeds observed during our study period. Forty-two migrated seeds were observed in the thorax, one was observed in the right kidney, 28 were observed in the pelvis and two were observed in the thigh. 1162 Prostate swelling and seed migration (P ¼ 0.667), the prostate volume on post-planning day 30 (ml) (P ¼ 0.925) or the percentage of prostate resolution (P ¼ 0.07). These data suggest that a larger amount of prostate swelling might be associated with seed loss from the prostate. We set the cutoff point for the prediction of seed migration as a swelling rate of 102.3% (the mean percentage of prostate swelling from the pre-planning to post-planning stages on day 0 of the migration-negative group þ SD). The sensitivity of this cutoff point was 81.1% and its specificity was 90.9%.
DISCUSSION
This study demonstrated two main findings. First, free seed migration is a serial phenomenon. And second, the prostate swelling that occurs between pre-planning and post-planning (day 0) measurements is significantly associated with seed migration, in disagreement with previously published reports based on chest X-ray monitoring (3) (4) (5) . This argument seems valid based on the results of regular monitoring using whole body scintigraphy as well as traditional radiographies of the trunk. As we reported previously, scintigraphy has a sensitivity of 100%, whereas radiography has a sensitivity of only 35% (6) . This large difference in the sensitivities of migration monitoring methods may be one of the major factors for the disagreement between studies, and the high sensitivity of scintigraphy may enhance the validity of our observations.
No consensus has been made as to which modality should be employed for measuring the prostate volume. Each modality has advantages and disadvantages. US suits the pre-planning stage. No special preparations are needed, and pre-planning and brachytherapy are performed with the patients in the exact same lithotomy position. US imaging provides a clear contour of the prostate, which should reduce interpretation discrepancies among brachytherapists. However, this modality is not suitable for post-planning because the implanted seeds can cause artifacts and bleeding from the prostate impairs visualization. Imaging procedures such as fusion with images obtained using other modalities are not available. CT provides a good depiction of the implanted seeds and pubic bones. CT imaging suits the postplanning stage. MRI has excellent soft-tissue resolution with arbitrary imaging planes. But post-planning seed imaging using MRI is generally inferior to that using CT. Furthermore, MRI does not suit the post-planning objectives, as it cannot identify implanted seeds. Added to this, the medical cost is high. Post-operative edema appears to resolve with a half-life of about 10 days, and the most reproducible dosimetric results can be obtained with a post-operative interval of 1 month. Fusion processing with CT images might be useful for reducing discrepancies among brachytherapists' contouring. For these reasons, MRI should be performed during the second post-planning observation.
Prostate tissue has long been recognized as an unpredictable matrix for holding radioactive seeds. The volume of the prostate has also been commonly observed to change daily (8) , not to mention during and after operations involving the insertion of numerous needles. A recently introduced realtime imaging method that enables constant observation of the prostate anatomy may reduce seed migration (9) .
Pubic arch interference has been suggested as one possible cause of technical difficulties during needle insertion (10) . It might be possible to argue that larger mechanical trauma to the prostate induces less seed fixity and future seed migration. Taussky et al. (11) demonstrated that the number of implanted seeds, the number of needles and the prostate volume during the pre-planning stage are associated with prostate edema. Our controversial results may be due to the use of a higher source strength (15.3 MBq) and androgen deprivation therapy. This protocol may result in prostate volume reduction, fewer needle insertions and the implantation of fewer seeds during the operation. Less mechanical trauma would likely induce a smaller inflammatory response and less bleeding.
Several groups have reported a variation in prostate position during the course of fractionated radiotherapy. Prostate 'Percentage of prostate swelling' is calculated as the prostate volume on post-planning Day 0 (ml)/prostate volume at pre-planning (ml)*100 (%). This parameter was significantly associated with seed migration (P , 0.0001). 'Percentage of prostate resolution' is calculated as the prostate volume on postplanning Day 0 (ml)/prostate volume at post-planning Day 30 (ml)*100 (%).
motion during the actual operation often makes procedures more challenging for brachytherapists; pushing the prostate cephalad with the needle can create a gap at the base, whereas pushing the prostate with the needle medially from the advancing needle creates a positioning that is too lateral. Prostate motion also causes extracapsular needle insertions, which may result in an unusual rate of prostate edema. The accumulation of gas in the intestines during the operation might affect the quality of images of the prostate. In addition to differences in the examination modalities used between pre-planning (transrectal US) and the initial post-planning (CT) measurements, the difference in the patients' posture between pre-planning (extended lithotomy position) and the initial post-planning (supine position) measurements might affect the calculation of the prostate volume. Several risk factors for seed migration have been discussed in previously published papers. One factor is the shape and construction of the seeds. Each seed measures 4.57 by 0.98 mm and consists of a cylinder-shaped titanium capsule. The major differences among the manufacturing companies are the design of the seed tip and edge among the manufacturers. Neither Merrick et al. (12) nor Older et al. (13) revealed any significant manufacturers' differences. Several studies have reported on the advantages of using stranded seeds over that of loose ones, as the stranded sources did not migrate until the Vicryl sutures dissolved. They also have the potential advantage of increasing the radiation dose to the outside of the prostate. Loose seeds can be implanted using either a preloaded needle or an applicator. Older et al. (13) suggested that the insertion method of the loose seeds in itself is not a major cause of migration. Our institution uses a relatively high-strength source that may require fewer needle insertions and a shorter operation time, which in turn may prevent the accumulation of excessive gas.
Prostate swelling or edema is known to be caused by traumatic needle and seed insertion and is often accompanied by bleeding. In other words, the swelling of the prostate gland may indicate the extent of bleeding. Supposing that hemodynamics are likely to be a major cause of seed migration, it might be safe to speculate that a large swelling volume may predict subsequent seed migration. The extent of swelling varies among patients, although we did not find any differences in potential factors between patients with a large amount of swelling and those with a small amount of swelling. The experience of the brachytherapist performing the procedure may also affect the amount of swelling. Unexperienced therapists may induce a larger amount of swelling. However, we do not have any definite evidence regarding factors that may induce seed migration other than the swelling of the prostate. Further studies using a highly sensitive scintigraphy technique are needed to elucidate the exact mechanism of seed migration.
To our knowledge, no other reports have suggested a close relationship between seed migration and deviations in prostate volume. The present paper serves as an expansion of our earlier study. Our previous report showed that scintigraphy had a 100% sensitivity and a 100% specificity, whereas radiography had a 35% sensitivity and a 100% specificity (6) . The high-quality images obtained using scintigraphy may explain this finding.
STUDY LIMITATION
In this study, the prostate volume was measured using different modalities during the pre-planning and post-planning stages (trans-rectal US during pre-planning and CT during post-planning). Some discrepancy in the prostate volumes measured using these methods may exist. Contrary to the well-known fact that the prostate volume should increase notably after implantation, this study indicated that the average volume during the pre-planning stage was somewhat similar to that during the post-planning stage. This result may partly be due to the use of androgen deprivation therapy for 3 weeks prior to implantation. However, these limitations are likely to lower the differences between the pre-and postplanning measurements of prostate volume, rather than enhance any differences. So, our results might represent an underestimation of the prostate volume deviation, rather than an overestimation, and we demonstrated a significant correlation between prostate volume deviation and seed migration despite the possibility of such an underestimation. Thus, we believe that our observations are valid.
During our study period, the new real-time imaging method combined with pre-planning was not a regular procedure. Stranded seeds are not available in Japan, and we did not investigate their seed fixity. Despite these limitations, our study is the first report to describe the application of high-sensitivity scintigraphic monitoring for migration analysis and to demonstrate that prostate volume deviation may be an important factor for predicting seed migration.
CONCLUSIONS
Prostate swelling between the pre-planning and post-planning (day 0) measurements was significantly associated with seed migration. Changes in the prostate volume after brachytherapy may affect subsequent seed migration and dose distribution to the prostate. Although no harmful effects from the migrated seeds have been reported, adequate attention should be given to this possibility.
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